These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3563691)

  • 21. Suppressed natural killer cell activity in ulcerative colitis.
    Tamura J; Jinbo T; Itoh K; Take H; Matsushima T; Murakami H; Kubota K; Tsuchiya J; Naruse T
    J Med; 1994; 25(5):337-40. PubMed ID: 7730739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of the leukocyte agglutination tests in patients with nonspecific ulcerative colitis under clinic and dispensary conditions].
    Shakhbazian AA
    Zh Eksp Klin Med; 1974; 14(3):45-50. PubMed ID: 4418998
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of steroid treatment on the expansion of ulcerative colitis. (Catamnestic studies)].
    Michel H; Scholz W
    Klin Wochenschr; 1967 Dec; 45(24):1250. PubMed ID: 5592462
    [No Abstract]   [Full Text] [Related]  

  • 24. Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis.
    Wenzl HH; Petritsch W; Aichbichler BW; Hinterleitner TA; Fleischmann G; Krejs GJ
    Z Gastroenterol; 1998 Apr; 36(4):287-93. PubMed ID: 9612926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral methotrexate in ulcerative colitis.
    Cummings JR; Herrlinger KR; Travis SP; Gorard DA; McIntyre AS; Jewell DP
    Aliment Pharmacol Ther; 2005 Feb; 21(4):385-9. PubMed ID: 15709988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association of cytomegalovirus colitis and the 1st episode of ulcerative colitis in an immunocompetent patient].
    Maté del Tío M; Peña Sánchez de Rivera JM; Larrauri Martínez J; Garcés Jiménez MC; Barbado Hernández FJ
    Gastroenterol Hepatol; 1996 Apr; 19(4):206-7. PubMed ID: 8665359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The surgeon and the management of ulcerative colitis: experience from the University of Benin Teaching Hospital, Nigeria.
    Ohanaka CE; Njoku TA
    Niger J Clin Pract; 2006 Dec; 9(2):176-8. PubMed ID: 17319354
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
    Kanke K; Nakano M; Hiraishi H; Terano A
    Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Salasopyrin treatment of patients with nonspecific ulcerative colitis].
    Levitan MKh
    Klin Med (Mosk); 1969 May; 47(5):102-6. PubMed ID: 4904549
    [No Abstract]   [Full Text] [Related]  

  • 30. Preoperative steroid-related complications in Japanese pediatric patients with ulcerative colitis.
    Uchida K; Araki T; Toiyama Y; Yoshiyama S; Inoue M; Ikeuchi H; Yanagi H; Miki C; Yamamura T; Kusunoki M
    Dis Colon Rectum; 2006 Jan; 49(1):74-9. PubMed ID: 16283565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fixed immunoglobulins in nonspecific ulcerative colitis].
    Shadrin BA; Konovich EA; Khalif IL
    Sov Med; 1983; (5):43-6. PubMed ID: 6351275
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab.
    Hassan C; Ierardi E; Burattini O; De Francesco V; Zullo A; Stoppino G; Panella C; Morini S
    Dig Liver Dis; 2007 Sep; 39(9):811-7. PubMed ID: 17652038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective intraarterial steroid injection in ulcerative colitis.
    Hiramatsu K; Asakura H; Baba S
    Acta Radiol Diagn (Stockh); 1976 May; 17(3):229-304. PubMed ID: 937043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of a chronopluricorticoid preparation].
    Gattoni A; Selce P; Siena AM; Giuliarini G; Altucci P
    Clin Ter; 1978 Aug; 86(3):229-40. PubMed ID: 743860
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful treatment of steroid refractory active ulcerative colitis with natural interferon-beta--an open long-term trial.
    Musch E; Andus T; Malek M; Chrissafidou A; Schulz M
    Z Gastroenterol; 2007 Dec; 45(12):1235-40. PubMed ID: 18080224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients.
    Takemoto K; Kato J; Kuriyama M; Nawa T; Kurome M; Okada H; Sakaguchi K; Shiratori Y
    Dig Liver Dis; 2007 May; 39(5):422-9. PubMed ID: 17379587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Certain problems of pathogenesis of nonspecific ulcerative colitis].
    Levitan MKh; Marko OP; Kapuller LL; Drozdov VN; Bolotin SM
    Ter Arkh; 1973 Jul; 45(7):66-70. PubMed ID: 4755071
    [No Abstract]   [Full Text] [Related]  

  • 40. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy.
    Nishioka C; Aoyama N; Maekawa S; Shirasaka D; Nakahara T; Tamura T; Fukagawa M; Umezu M; Abe T; Kasuga M
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.